The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10666702 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature